Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type.

Schifanella L., Barnett SW., Bissa M., Galli V., Doster MN., Vaccari M., Tomaras GD., Shen X., Phogat S., Pal R., Montefiori DC., LaBranche CC., Rao M., Trinh HV., Washington-Parks R., Liyanage NPM., Gorini G., Brown DR., Liang F., Loré K., Venzon DJ., Magnanelli W., Metrinko M., Kramer J., Breed M., Alter G., Ruprecht RM., Franchini G.